Diclofenac sodium microcapsules: In vitro testing considerations

Drug Development and Industrial Pharmacy

Volumn 23, Issue 3, 1997, Pages 273-283

  Palomo, M E ^a   Ballesteros, M P ^a   Frutos, P ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC;

ARTICLE; DISPERSION; DISSOLUTION; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG RELEASE; EMULSION; ENCAPSULATION; MICROCAPSULE;

EID: 0030906546     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709149804     Document Type: Article

References (51)

1. W. A. Hanson, Handbook of Dissolution Testing, 1990.
2. J. Swarbrick and J. C. Boylan, in Liposomes as Pharmaceutical Dosage Forms to Microencapsulation, Encyclopedia of Pharmaceutical Technology, Marcel Dekker, New York, 1994.
3. P. B. Deasy, in Coacervation-Phase Separation Procedures Using Aqueous Vehicles, Microencapsulation and Related Drug Processes, Marcel Dekker, New York, 1984.
4. A. Kondo, Microcapsule Processing and Technology, Marcel Dekker, New York, 1979.
5. Lapronenciere, Contribution à l'etude des modèles biopharmaceutiques permettant l'evaluation de la Biodesponibilité, Thèse, 1977.
6. C. Brossard and D. Wouessidjewe, STP Pharma Sci., 6, 728 (1990).
7. S. E. Leucuta, Int. J. Pharm., 54, 71 (1989).
8. Y. Nozawa and S. Fox, J. Pharm. Sci., 70, 385 (1981).
9. H. Natsume, K. Sugibayashi, and Y. Morimoto, Pharm. Res., 8, 185 (1991).
10. G. K. Vudathala and J. A. Rogers, Pharm. Res., 9, 759 (1992).
11. R. Ciftci, A. A. Hincal, and H. S. Kas. 6th Int. Conf. Pharm. Techn. APGI 2, 62 (1992).
12. R. Bodmeier, H. Wang, and J. Herrman, STP Pharma Sci., 4, 275, (1994).
13. R. S. Bhanja and T. K. Pal, Boll. Chim. Farm., 131, 239 (1992).
14. K. Egbaria and M. Friedman, J. Pharm. Sci., 14, 79 (1990).
15. I. Maharaj, J. C. Nairn, and J. B. Campbell, J. Pharm. Sci., 73, 39 (1984).
16. M. E. Meshali, A. E. El-Helw, and E. A. El-Fattah, Acta Pharm. Fennica, 101, 135 (1992).
17. P. L. Madan and R. Chareoboonsit, Pharm. Res., 6, 714 (1989).
18. M. C. Andry, D. Bocquet, H. Jacquesson, and M. C. Lévy, 5th. Int. Conf. Pharm. Tech. APGI, 5, 78 (1989).
19. S. M. Ahmed, S. I. Saleh, S. I. Abdel-Rahman, S. H. Khidr, A. E. Aboutaler, and A. H. Ali, STP Pharm Sci., 2, 205 (1992).
20. F. Delgay, A. M. Sautereau, S. J. Allie-Daram, and A. Combes, 6th Int. Conf. Pharm. Tech. APGI, 2, 294 (1992).
21. C. Zinutti, F. Kedzierewicz, L. Picard, M. Barberi, J. L. Merlin, M. Hoffman, and P. Maincent, 6th Int. Conf. Pharm. Tech. APGI, 2, 262 (1992).
22. M. S. Harris, J. Pharm. Sci., 70,391 (1981).
23. I. Orienti, V. Bertasi, and V. Fecchi, 6th Int. Conf. Pharm. Tech. APGI, 2, 223, (1992).
24. M. Follidis and S. E. Leucuta, 6th Int. Conf. Pharm. Tech. APGI, 2, 73, (1992).
25. J. Sjövall, R. Sjöquist, B. Huitfeldt, and H. Nyquist, J. Pharm. Sci., 73, 141 (1984).
26. Y. Koida, M. Kobayashi, and M. Samejima, Chem. Pharm. Bull., 34, 3354 (1986).
27. M. C. Lévy and D. Guérin, Pharm. Acta Helv., 62, 236 (1987).
28. M. G. Moldenhauer and J. G. Nairn, J. Pharm. Sci., 79, 659 (1990).
29. A. J. Shukla and J. C. Price, Pharm. Res., 8, 1396, (1991).
30. S. A. El-Harras, S. Shawky Tous, A. M. El-Sayed, and H. W. Sun, STP Pharm Sci., 1(4), 262 (1991).
31. H. Takahata, T. Osawa, and M. Kobayashi, Chem. Pharm. Bull., 40, 729 (1992).
32. G. García Encina, S. P. Sanghui, and S. G. Nalrn, Drug Dev. Ind. Pharm., 18, 561 (1992).
33. A. Nokhodchi and D. Farid, STP Pharma Sci., 2, 279 (1992).
34. H. P. Merkle and P. Speiser, J. Pharm. Sci., 62, 1444 (1973).
35. B. Gander, R. Gurny, E. Doelkner, and N. A. Peppas, Pharm. Res., 6, 587 (1989).
36. P. Sansdrap and A. J. Möes, 6th Int. Conf. Pharm. Tech., APGI, 2, 243 (1992).
37. I. Racz, Drug Formulation, Wiley, Budapest, 1989, p. 165.
38. D. J. Chetty, M. O. Ogundeji, L. A. Damani, V. H. Dawes, and M. C. Solomon, Pharm. Tech. Eur., November, 28 (1994).
39. A. Navarro and M. P. Ballesteros, STP Pharma Pratiques, 4, 108 (1994).
40. S. I. Saleh, S. H. Khider, J. M. Aiache, E. Beyssac, and R. Camacho, STP Pharma Sci., 2, 242 (1992).
41. J. C. Bain, S. B. Tan, D. Ganderton, and M. C. Solomon, 5th Int. Conf. Pharm. Tech., APGI, 2, 349 (1989).
42. M. Hasan, N. Najib, M. Suleiman, M. Y. El-Sayed, and M. Abdel-Hamid, Drug Dev. Ind. Pharm., 18, 1981 (1992).
43. A. Gürsoy, M. Türkoglu, L. Eroglu, S. Aygin, and I. Okar., Proc. 1st World Meeting APGI/APV, Budapest, May 9/11, 1995, p. 433.
44. M. Acikgoz, H. S. Kas, and A. A. Hincal, 6th Int. Conf. Pharm. Tech. APGI, 2, 232 (1992).
45. D. Torres, G. García Encina, B. Seijo, and J. L. Vila-Jato, 6th. Int. Conf. Pharm. Tech. APGI, 5, 262, 1992.
46. G. García Encina, D. Torres, B. Seijo, M. J. Isla, and J. L. Vila-Jato, 10th. Pharm. Conf. Tech., 1, 466, (1991).
47. S. Y. Lin and Y. H. Kao, Proc. Int. Symp. Control. Re. Bioact. Mater., 18, 155 (1991).
48. A. Peña-Romero, M. Poncet, J. C. Jinot, and D. Chulia, Pharm. Acta Helv., 63, 309 (1988).
49. A. Fini, G. Fazio, I. Orienti, V. Bertasi, V. Zecchi, and I. Rapaport, Eur. J. Pharm. Biopharm., 38, 66 (1992).
50. M. Samejima, G. Hirata, and Y. Koida, Chem. Pharm. Bull., 30, 2894 (1982).
51. M. P. Ballesteros, Farmacotecnica de formas orales sólidas y su evaluación biofarmaceutica mediante datos de excreción renal, Thesis, 1985.